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One sentence summary: ER stress-induced IgA protects from enteritis   45 
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3 
Abstract 46 
Immunoglobulin A (IgA) is the major secretory immunoglobulin isotype at mucosal surfaces, 47 
where it regulates microbial commensalism and excludes luminal factors from contacting 48 
intestinal epithelial cells (IECs). IgA is induced by T cell-dependent and -independent (TI) 49 
pathways. However, little is known about TI regulation. We report that IEC endoplasmic 50 
reticulum (ER) stress induces a polyreactive IgA response, which is protective against enteric 51 
inflammation. IEC ER stress causes TI and microbiota-independent expansion and activation of 52 
peritoneal B1b cells, which culminates in increased LP and luminal IgA. Increased numbers of 53 
IgA-producing plasma cells are observed in healthy humans with defective autophagy, who are 54 
known to exhibit IEC ER stress. Upon ER stress, IECs communicate signals to the peritoneum 55 
that produce a barrier-protective TI IgA response.  56 
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Main text  57 
The intestinal epithelium is continuously confronted with potentially deleterious environmental 58 
stimuli (1). These exposures and the underlying secretory burden of intestinal epithelial cells 59 
(IECs) are challenging for this cell type. Thus endoplasmic reticulum (ER) stress and the 60 
accompanying unfolded protein response (UPR) are commonly observed in IECs under 61 
homeostasis (2) and increased in inflammatory bowel disease (IBD) (3, 4). In IBD, ER stress in 62 
the IEC can serve as a nidus for spontaneous microbiota-dependent ileitis. This can be seen in 63 
mice with an IEC-restricted deletion of the important UPR effector molecule X box binding 64 
protein-1 (Xbp1ΔIEC) (3, 5). It is unknown however whether IEC-associated ER stress can also 65 
elicit barrier-protective immune responses. 66 
We observed elevated numbers of IgA+ plasma cells (CD45+CD3−IgA+B220−) in small-intestinal 67 
lamina propria (SI LP) and increased concentrations of ileal tissue IgA in Xbp1ΔIEC mice 68 
compared to littermate Xbp1fl/fl controls (Fig. 1A and B, Fig. S1). Secretory (s)IgA, which 69 
functions to protect the mucosa by coating and entrapping commensal and colitogenic bacteria 70 
(6) and excluding intraluminal factors from IEC contact (7, 8), was also increased in the lumen 71 
(Fig. 1C). This was associated with increased circulating IgA levels as early as 6 weeks of age 72 
(Fig. 1D), prior to the emergence of spontaneous inflammation in Xbp1ΔIEC mice. No other Ig 73 
isotypes were increased in the SI (Fig. S2A) or sera (Fig. S2B) of Xbp1ΔIEC mice. The increased 74 
number of IgA+ cells in Xbp1ΔIEC mice accumulated around SI crypts (Fig. 1E and F), where ER 75 
stress (5, 9) and basal plasmacytosis, a feature of IBD (10), frequently occurs.  76 
Xbp1 deletion in IECs results in UPR activation including the ER-stress sensor inositol-requiring 77 
enzyme 1 α (IRE1α) (11). Double conditional knockout mice lacking both IRE1α and XBP1 in 78 
IECs (Ern1/Xbp1ΔIEC) showed no increase in SI IgA+ cell numbers compared to Ern1/Xbp1fl/fl 79 
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controls (Fig. S3), indicating that IRE1α is an important mediator of the IgA response. We 80 
extended these observations to an inducible IEC-specific knockout of the ER-stress sensor 81 
glucose related protein 78 (GRP78) (12). Grp78T-ΔIEC mice exhibited a rapid increase in SI IgA+ 82 
plasma cells by 3 days after Grp78 deletion (Fig. 1G). Conversely, treatment of Xbp1ΔIEC mice 83 
with the chemical chaperone tauroursodeoxycholic acid (TUDCA) (13) reduced IEC ER stress 84 
(Fig. S4) and prevented the IgA response in the SI LP (Fig. 1H) and plasma (Fig. 1I). 85 
We next generated Igha−/−Xbp1ΔIEC mice and Igha−/−Xbp1fl/fl controls. Consistent with previous 86 
studies (3), Xbp1ΔIEC mice developed spontaneous ileitis, which was unchanged under conditions 87 
of IgA deficiency (Fig. 1J). However, inflammation in Igha−/−Xbp1ΔIEC mice significantly 88 
extended proximally into the jejunum (Fig. 1K and Fig. S5, histology score and H&E, 89 
respectively), suggesting that IEC ER stress–induced IgA+ plasma cells protect from 90 
inflammation. Like humans with selective IgA deficiency (14), Igha−/− mice exhibited a 91 
compensatory increase of LP IgM+ plasma cell numbers that was further elevated with IEC ER 92 
stress (Igha−/−Xbp1ΔIEC, Fig. 1L). We thus generated B cell–deficient Xbp1ΔIEC mice 93 
(µMT Xbp1ΔIEC), lacking intestinal LP plasma cells (IgA IHC shown in Fig. S6). These animals 94 
showed no significant worsening of inflammation in either the jejunum or ileum compared to 95 
Igha−/−Xbp1ΔIEC controls (Fig. 1K and S5, histology scores and H&E, respectively), indicating 96 
that in mice, compensatory IgM did not contribute to protection. This was likely due to its 97 
relatively low levels compared to IgA (Fig. S7), a reduced ability of IgM to bind several typical 98 
IgA targets (15), and/or differences in sIgM function in mice compared to humans (16). Further, 99 
the elevated numbers of IgA+ plasma cells in Xbp1ΔIEC mice were not due to increased levels of 100 
interleukin (IL)-10, which can be produced by B cells (17)—SI tissue from µMT Xbp1ΔIEC and 101 
Xbp1ΔIEC mice or Xbp1ΔIEC mice crossed with an IL-10-GFP reporter line (Vert-X) exhibited 102 
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similar levels of IL-10 (Fig. S8A) and/or frequencies of reporter+ LP B cells (Fig. S8B) 103 
compared to their respective littermate controls. 104 
We examined if luminal IgA secretion was required for the protective role observed by 105 
generating a polymeric immunoglobulin receptor/Xbp1 double-deficient mice (Pigr−/−Xbp1ΔIEC), 106 
which are unable to transport IgA and IgM across the IEC (18). Pigr−/− Xbp1ΔIEC mice showed an 107 
increase of LP IgA+ plasma cells similar to Xbp1ΔIEC animals (Fig. 1M and N), but still 108 
developed severe inflammation of the proximal SI (Fig. 1O and Fig. S5, histology scores and 109 
H&E, respectively). This phenocopied Igha−/−Xbp1ΔIEC and µMT Xbp1ΔIEC animals and indicated 110 
a protective role for sIgA in this model. Although Xbp1ΔIEC animals exhibited increased IgA 111 
coating of fecal bacteria compared to Xbp1fl/fl controls (Fig. 1P), IgA-SEQ (6) revealed no major 112 
differences between Xbp1ΔIEC and Xbp1fl/fl mice in the taxa-specific coating of commensal 113 
bacteria with IgA, suggesting a specific IgA-targeted microbe was not responsible (Fig. S9). 114 
Intestinal IgA+ plasma cells can differentiate via T cell-dependent (TD) and T cell-independent 115 
(TI) pathways (19, 20). Although we observed a small increase in germinal center B cells 116 
(B220+CD19+CD95+GL7+) in Peyer’s patches (PP) of Xbp1ΔIEC mice compared to Xbp1fl/fl 117 
controls (Fig. 2A), TD pathways were not involved in the IgA induction. First, T follicular helper 118 
cell percentages (Tfh, CD3+CD4+ICOS+PD-1hiCXCL5hi) (7) were similar in the PP and 119 
mesenteric lymph nodes (MLN) of Xbp1ΔIEC mice compared to Xbp1fl/fl controls (Fig. 2B). 120 
Second, T cell receptor β-deficient TCRβ−/−Xbp1ΔIEC mice exhibited increased SI LP IgA+ 121 
plasma cell numbers (Fig. 2C) without changes in LP γδ T cells (Fig. S10) compared to 122 
TCRβ−/−Xbp1fl/fl controls. Finally, PP-deficient (PPdef) Xbp1ΔIEC (21) continued to exhibit 123 
increased SI LP IgA+ plasma cells (Fig. 2D) without proximal extension of SI inflammation (Fig. 124 
S11), compared with PPdefXbp1fl/fl littermate controls.  125 
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In contrast, we observed increased percentages and numbers of B1b (CD5−CD19+CD23−CD43+), 126 
but not B1a (CD5+CD19+CD23−CD43+), cells in the peritoneal cavities of Xbp1ΔIEC mice 127 
compared to Xbp1fl/fl littermate controls (Fig. 2E and 2F). B1 cells associated with TI pathways 128 
emerge and migrate from there to the intestine giving rise to polyreactive IgA-producing plasma 129 
cells in the SI (19, 22, 23). As this suggested a transmissible factor, we conducted parabiosis 130 
experiments in which CD45.1+ wild-type (wt) mice were joined to CD45.2+ Xbp1ΔIEC mice or 131 
Xbp1fl/fl controls (Fig. 2G). Three weeks after parabiosis, we observed T and B cell chimerism in 132 
blood of ~50% (Fig. 2H). Consistent with their tissue-resident phenotype, peritoneal B1 cells 133 
exhibited ~20% chimerism (Fig. 2H). The peritoneal B1 cell compartments of wt CD45.1 mice 134 
showed increased numbers of CD45.1+ B1b cells in animals joined to CD45.2+ Xbp1ΔIEC mice 135 
compared to those joined to CD45.2+ Xbp1fl/fl controls (Fig. 2I, gating strategy in Fig. S12). 136 
There were also more CD45.1+ IgA+ plasma cells in the SI LP of CD45.2+ Xbp1ΔIEC mice 137 
compared to CD45.2+ Xbp1fl/fl controls, which lacked ER stress in their intestinal epithelium 138 
(Fig. 2J). In contrast, CD45.1+IgA+ plasma cells in the LP of CD45.1+ animals were not 139 
increased (Fig. 2K).  Notably, there were no significant changes in SI Tnfsf13 (April), Tnfsf13b 140 
(Baff), Ccl25, Ccl28 and Cxcl13 (Fig. S13A) expression or TSLP protein levels. (Fig. S13B), 141 
which have been implicated in TI IgA class switching and/or plasma-cell recruitment (24). 142 
Germ-free (GF) Xbp1ΔIEC mice, compared to GF Xbp1fl/fl controls, also exhibited increased 143 
numbers of SI IgA+ plasma cells (Fig. 3A and B), basal plasmacytosis (Fig. 3B), higher 144 
frequencies and numbers of peritoneal B1b cells (Fig. 3C and D), and an elevated proportion of 145 
IgA+ cells among the SI LP B1b-like cell compartment (CD5−CD19+CD43+) (Fig. 3F). They also 146 
showed heightened IEC ER stress (Fig. S14A–C) without spontaneous enteritis (5) and few SI 147 
epithelial apoptotic events compared to SPF Xbp1ΔIEC mice (Fig. S14D). GF Xbp1ΔIEC mouse 148 
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colons also showed increased numbers of IgA+ plasma cells (Fig. S15A) and higher levels of 149 
tissue IgA (Fig. S15B) compared to littermate controls. However, colonic IgA+ plasma cell 150 
numbers and IgA tissue levels in SPF Xbp1ΔIEC and Xbp1fl/fl mice were similar (Fig. S15A and 151 
B), suggesting that high levels of TD IgA production in the colon mask the TI ER stress-induced 152 
IgA response under SPF conditions (25). 153 
Thus, the increase in IgA+ plasma cells was not restricted to the SI nor dependent on apoptosis, 154 
microbiota, or a pro-inflammatory milieu but, rather, was due to IEC ER stress-driven 155 
recruitment of TI peritoneal B1b cells. Indeed, although single-cell RNA sequencing (RNA-seq) 156 
of the peritoneal lavage of GF Xbp1ΔIEC mice and Xbp1fl/fl controls identified heterogenous 157 
populations of peritoneal myeloid and T cell subsets (Fig. 3F–H and Fig. S16A–B), the only 158 
peritoneal cell type demonstrating a major expansion in the context of IEC ER stress was a 159 
cluster containing a B1b-like transcriptional signature (cluster 2, Fig. 3F–H and Fig. S16A–B). 160 
Flow cytometry confirmed absence of peritoneal myeloid or T cell alterations (Fig. S17) or 161 
changes in SI LP myeloid cell populations (Fig. S18). Peritoneal B1b cells from GF Xbp1ΔIEC 162 
mice were also transcriptionally distinct.  Differential expression (Fig. 3I) and gene set 163 
enrichment analysis (GSEA, Fig. 3J) of purified B1b cells from GF Xbp1ΔIEC mice showed the 164 
upregulation of genes involved in protein biosynthesis, oxidative phosphorylation, and Myc 165 
signaling—which is critical for B cell activation (26)—compared to GF littermate controls. In 166 
contrast, cell adhesion gene sets were downregulated in line with the increased ability of these 167 
B1b cells to egress from the peritoneal cavity and home to ER-stressed SI epithelium (Fig 3J). 168 
Taking advantage of the increased circulating IgA levels present in GF Xbp1ΔIEC mice compared 169 
to GF Xbp1fl/fl mice (Fig. 3K), we functionally confirmed the B1 origin of the IgA response by 170 
showing the IgA derived from these animals efficiently coated fecal microbiota obtained from 171 
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µMT mice lacking immunoglobulins (Fig. 3L) and exhibited broad reactivity to endogenous and 172 
exogenous antigens (Fig. 3M) as expected (23, 25). Furthermore, analysis of variable-region 173 
usage and CDR3 clonotype sequences from the proximal and distal intestinal segments of GF 174 
animals demonstrated the existence of a similar IgA+ cell polyclonal repertoire (Fig. S19A–C) 175 
containing a limited CDR3 region mutational load (Fig. S19D) regardless of genotype.  176 
Lastly, mice with a conditional deletion of Atg16l1 in IECs (Atg16l1ΔIEC) exhibit SI IEC ER 177 
stress without histopathologic signs of inflammation (5, 11). These animals exhibited increased 178 
numbers of SI LP IgA+ cells (Fig. 4A) and a specific increase in peritoneal B1b cells (Fig. 4B). 179 
Similarly, SI biopsies of healthy human subjects homozygous for the hypomorphic 180 
ATG16L1T300A variant, who are known to exhibit increased ER stress (27), exhibited increased 181 
numbers of LP IgA+ cells compared to both non-carriers and heterozygous subjects (Fig. 4C). 182 
Thus, the secretion of IgA into the lumen and resultant innate-like polyreactive responses protect 183 
ER-stressed mucosa in a pathway under the control of IEC ER stress. This occurs independently 184 
of either microbes or inflammation, making it a self-contained, host-derived response. This 185 
response is TI, peritoneal B1b cell-derived, and under the control of an unknown transmissible 186 
factor that emerges from ER stress in the IEC and is communicated to the peritoneal cavity, 187 
revealing a tight link between these two anatomic sites. In the absence of IgA or its secretion, 188 
spontaneous enteritis emerges. We propose that this homeostatic function of epithelial ER stress 189 
is a beneficial “eustress” response that is functionally opposed to its well described involvement 190 
in pro-inflammatory pathways.   191 
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Figure Legends 328 
Fig. 1. Intestinal epithelial ER stress induces a protective IgA response. (A) Absolute counts 329 
of SI LP IgA+ plasma cells in Xbp1ΔIEC mice and Xbp1fl/fl controls at 10 weeks of age (n = 7–8). 330 
(B) Ileal tissue IgA normalized by total soluble tissue protein (n = 8–10). (C) IgA concentration 331 
in SI washes (n = 6–10). (D) Circulating IgA concentration (n = 6–10 for each age). (E and 332 
F) Representative images (E) and quantification (F) of LP IgA+ cells (brown) along ≥ 50 ileal 333 
crypt–villus axes (n = 6–7). Magnified area depicts basal plasmacytosis. (G) Representative 334 
images and quantification of SI LP IgA+ cells (red) in Grp78T-ΔIEC mice and Grp78fl/fl controls 335 
after 3 days of tamoxifen treatment (n = 4). (H and I) Absolute counts of SI LP IgA+ plasma cells 336 
(H) and circulating IgA concentrations (I) of the indicated genotypes, treated with either TUDCA 337 
(2 mg/ml) in the drinking water or plain water (control) for two weeks (n = 7–8). 338 
(J and K) Enteritis scores of ileal (J) and jejunal (K) sections of indicated genotypes. (n = 4–26). 339 
(L) Representative plots, frequencies, and absolute counts of SI LP IgM+ plasma cells (gated on 340 
CD45+CD3− lymphocytes) of the indicated genotypes (n = 3–14). (M to O) Absolute flow 341 
cytometric counts of SI LP IgA+ plasma cells (M), representative images and quantification of 342 
IgA+ cells in ileal sections (N) and enteritis scores (O) of Pigr−/− Xbp1ΔIEC mice and 343 
Pigr−/− Xbp1fl/fl controls (n = 9–18). (P) Frequencies of IgA-coated fecal bacteria from the 344 
indicated genotypes as determined by flow cytometry (n = 2–20). B6, C57BL/6J background. 345 
Scale bars, 100 µm (low magnification) or 20 µm (insets). Symbols represent individual animals. 346 
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Bars represent arithmetic means (B, D, F, G, I, N and P), medians (J, K and O)2 or geometric 347 
means (A, C, H, L and M). Error bars indicate standard error of mean. Data are representative of 348 
three (A and B) independent experiments or were compiled from two (M) or three (L and P) 349 
experiments. P-values were calculated by unpaired Student’s t-test (A to D, F, G, L to N, P), 350 
Kruskal–Wallis test with Dunn’s post test (J and K), Mann–Whitney U test (O), or two-way 351 
ANOVA with Fishers LSD method and two-stage step-up method of Benjamini, Krieger, and 352 
Yekutieli to control the false discovery rate (H and I). *P < 0.05, **P < 0.01, ***P < 0.001. 353 
 354 
Fig. 2. ER stress-induced IgA is PP- and T cell-independent and involves recruitment of 355 
peritoneal B1b cells by a transmissible factor. (A) Representative plots and percentages of 356 
germinal center (GC) B cells (gated on CD19+ lymphocytes) in MLN and PP of Xbp1ΔIEC mice 357 
and Xbp1fl/fl controls (n = 4–7). (B) Representative plots and percentages of MLN and PP 358 
follicular T helper cells (Tfh, gated on CD3+CD4+ lymphocytes, n = 4–6). (C) Absolute counts of 359 
SI LP IgA+ plasma cells in TCRβ−/−Xbp1ΔIEC mice and TCRβ−/−Xbp1fl/fl controls (n = 8–9). 360 
(D) Absolute counts of SI LP IgA+ plasma cells in PP-deficient Xbp1ΔIEC mice and Xbp1fl/fl 361 
controls (n = 6–8). (E and F) Representative plots, percentages, and absolute counts of peritoneal 362 
B1a and B1b cells in Xbp1ΔIEC mice and Xbp1fl/fl controls (n = 5–7). (G) Schematic 363 
representation of the parabiosis experiment (n = 7–8 pairs per genotype). (H) Frequencies of 364 
CD45.1+ circulating lymphocytes and CD45.1+ peritoneal B1 cells 3 weeks after parabiotic 365 
surgery. Dotted line indicates 50% chimerism. (I) Absolute numbers of CD45.1+ B1b cells in 366 
peritoneal cavities of CD45.1 animals, conjoined with Xbp1fl/fl and Xbp1ΔIEC mice, respectively. 367 
(J and K) Absolute numbers of SI LP CD45.1+IgA+ plasma cells in parabiotic Xbp1fl/fl and 368 
Xbp1ΔIEC mice (J) and in CD45.1 parabionts, conjoined with Xbp1fl/fl and Xbp1ΔIEC mice, 369 
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respectively (K). Symbols represent individual animals. Bars represent arithmetic means (A, B, 370 
E, and H) or geometric means (C, D, F, I–K). Data are representative of three experiments (E and 371 
F) or were pooled from two experiments (C, D, G–K). P-values were calculated by unpaired 372 
Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001. 373 
 374 
Fig. 3. Epithelial ER stress-derived IgA is microbiota- and inflammation-independent and 375 
polyreactive in nature. (A) Absolute counts of SI LP IgA+ plasma cells in germ-free (GF) 376 
Xbp1ΔIEC mice and Xbp1fl/fl controls (n = 7–8). (B) Representative images and quantification of 377 
LP IgA+ cells (green) along ≥ 50 ileal crypt-villus axes (n = 3–6). Nuclei are counterstained with 378 
DAPI (blue). Arrows indicate basal plasmacytosis. (C and D) Frequencies (% of 379 
CD19+CD23−CD43+ cells) and absolute flow cytometric counts of peritoneal B1a and B1b cells 380 
(n = 7–8). (E) Representative plots (gated on CD5−CD19+CD43+ lymphocytes) and frequencies 381 
of IgA+ B1b-derived cells in SI LP of GF Xbp1ΔIEC mice and GF Xbp1fl/fl controls (n = 7–8). 382 
(F) t-SNE plot depicting unsupervised clustering of single-cell transcriptomes (n = 11,104 cells) 383 
from peritoneal lavages of Xbp1ΔIEC mice and Xbp1fl/fl controls (aligned data sets). 384 
(G) Expression levels of canonical markers for macrophages (Csf1r), B cells (Cd79a), T cells 385 
(Cd3e), and peritoneal dendritic cells (Cd209a) in t-SNE plot. (H) t-SNE plot as in (F) with cells 386 
colored by genotype. Bar graph depicts numbers of cells within each cluster by genotype. 387 
(I) Volcano plot showing log2-transformed fold-change (log2FC) of gene expression in B1b cells 388 
from GF Xbp1ΔIEC mice compared to GF Xbp1fl/fl controls (n = 5–7). Differentially expressed 389 
genes (log2FC ≥ 1 or ≤ −1, FDR < 0.05) are highlighted in blue. FDR values < 10−5 are plotted at 390 
10−5 (triangles). (J) GSEA enrichment plots for selected gene sets. NES, normalized enrichment 391 
score. (K) Circulating IgA concentrations in GF Xbp1ΔIEC mice and Xbp1fl/fl controls (n = 12–13). 392 
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(L) Representative plots (gated on SYBRhi events) and frequencies of IgA coating on fecal 393 
bacteria from µMT mice that were incubated with sera from GF Xbp1ΔIEC mice or Xbp1fl/fl 394 
controls (n = 4–5). (M) Polyreactivity ELISA OD650 values of serum IgA from GF Xbp1ΔIEC 395 
mice or Xbp1fl/fl controls (n = 5–6) against the indicated antigens. Scale bar, 100 µm. Symbols or 396 
lines represent individual animals. Bars represent arithmetic means (B, C and E) or geometric 397 
means (A, D and K). Data are representative of at least two independent experiments (B to D, L 398 
and M) or were pooled from two experiments (A, E and K). P-values were calculated by 399 
unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001. 400 
 401 
Fig. 4. Defective ATG16L1-dependent autophagy results in a peritoneal B1b response in 402 
mice, and IgA induction in both mice and humans. (A) Representative images and 403 
quantification of LP IgA+ cells (brown) along ≥ 50 ileal crypt-villus axes of Atg16l1ΔIEC mice 404 
and Atg16l1fl/fl controls (n = 8). (B) Absolute counts of peritoneal B1a and B1b cells in 405 
Atg16l1ΔIEC mice and Atg16l1fl/fl controls (n = 7–12). (C) Representative images and 406 
quantification of IgA+ cells (brown) in ileal biopsies of healthy human subjects, shown by 407 
ATG16L1 genotype (n = 8–16). Scale bar, 100 µm. Symbols represent individual animals or 408 
human subjects. Bars represent arithmetic means (A and C) or geometric means (B). Data in (B) 409 
were pooled from two experiments. P-values were calculated by unpaired Student’s t-test (A and 410 
B) or one-way ANOVA with Holm–Šídák test (C). *P < 0.05, **P < 0.01, ***P < 0.001. 411 
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2Materials and Methods
Mice
C57BL/6J Villin-cre+;Xbp1fl/fl (Xbp1ΔIEC), Villin-cre+;Ern1fl/fl;Xbp1fl/fl (Ern1/Xbp1ΔIEC) and 
Villin-cre+;Atg16l1fl/fl (Atg16l1ΔIEC) mice were obtained as described before (5). C57BL/6J TCRβ−/− 
mice (B6.129P2‑Tcrbtm1Mom/J), μMT mice (B6.129S2‑Ighmtm1Cgn/J), CD45.1 mice (B6.SJL‑
PtprcaPepcb/BoyJ) and IL-10 reporter mice (Vert-X, B6(Cg)-Il10tm1.1Karp/J) were purchased 
from Jackson Laboratories. Igha–/– mice (Ighatm1Grh) were provided by Dr. M. Conner (28), and 
Pigr–/– mice (B6.129P2‑Pigrtm1Fejo) obtained from Dr. C.S. Kaetzel and Dr. M. Karin (18, 29). Mice 
were analyzed at 10–12 weeks of age unless otherwise indicated. For all conditional knockouts, 
sex‑ and age‑matched Villin-cre– littermates were used as controls. All mice were maintained in 
a specific pathogen-free environment at Harvard Medical School or at the central biomedical 
services facility of the University of Cambridge, UK (Ern1/Xbp1ΔIEC, Atg16l1ΔIEC), according to 
institutional guidelines and the approval of relevant authorities. 
Germ‑free C57BL/6 Villin-cre+;Xbp1fl/fl (GF Xbp1ΔIEC) mice and their littermate controls 
Villin-cre–;Xbp1fl/fl mice were obtained as described before (5), and housed at the Harvard 
gnotobiotic facility under strict germ‑free conditions.
Experiments with the C57BL/6 Villin-creERT2+;Grp78fl/fl (Grp78T-ΔIEC) mice were performed in 
the Academic Medical Center Animal Research Institute in accordance with local guidelines. 
Villin-creERT2 mice have been described previously (30). Grp78fl/fl mice (Hspa5tm1Alee) were kindly 
provided by the Lee lab (12). For Cre‑ERT2‑mediated recombination, mice were administered three 
intraperitoneal injections of 50 mg/kg tamoxifen (Sigma-Aldrich, 10 mg/ml in corn oil) during 
three consecutive days and were sacrificed 24 hours thereafter.
Cell isolation
Lamina propria: 10 cm of distal small intestine was excised and mesenterium, fat, intestinal 
contents and Peyer’s Patches were carefully removed. Intestines were opened longitudinally 
and cut into 1–2 cm pieces. Samples were then placed into a 50-ml tube with 20 ml of HBSS 
3 mM EDTA (Fisher) and incubated for 10 minutes at 37 °C and 250 rpm on a shaking incubator 
(New Brunswick Scientific I2500). The supernatant, containing mucus and epithelial debris, 
was discarded and the wash steps repeated twice for another 10 and 20 minutes, respectively, 
using fresh HBSS 3 mM EDTA. The tissue pieces were then collected, washed once in HBSS 
and placed into a new 50-ml tube with 10 ml of RPMI 10% FBS (Atlanta Biologicals), 1.5% 
HEPES (Corning), antibiotic/antimycotic (Gibco), 1 mg/ml of collagenase VIII, and 50 µg/ml of 
DNase I (both Sigma). Samples were incubated for 30 minutes at 37 °C and 250 rpm. Supernatant 
containing isolated cells was then passed through a 100-µm cell strainer, washed with PBS 
2% FBS, 2 mM EDTA, passed through a 40-µm cell strainer and washed again.
3Peyer’s patches and mesenteric lymph nodes (MLNs): Peyer’s patches and MLNs were minced 
and passed through a 70-µm cell strainer with the plunger end of a 1-ml syringe, washed once in 
PBS 2% FBS, 2 mM EDTA and passed again through a 40-µm cell strainer.
Peritoneal cells: The isolation of peritoneal cavity cells was performed as described previously (31). 
Briefly, the peritoneal lining of a euthanized mouse was exposed by carefully cutting and pulling 
back the outer skin layer. Then, 5 ml of ice-cold PBS 2% FBS, 2 mM EDTA was injected into the 
peritoneal cavity using a 27G needle. The peritoneum was gently massaged to dislodge cells and 
the peritoneal contents collected using a 25G needle. Samples with visible blood contamination 
were discarded. Peritoneal contents were washed once in PBS 2% FBS, 2 mM EDTA and passed 
through a 40-µm cell strainer.
Flow cytometry
Single‑cell suspensions were incubated with anti‑mouse CD16/32 (clone 93, Biolegend) and with 
Fixable Viability Dye (eBioscience, each 20 minutes at 4 °C) prior to staining. Antibodies used for 
staining are listed in Table S1. Cells were incubated in antibody cocktail in PBS 2% FBS, 2 mM 
EDTA for 30 minutes at 4 °C. When required, intracellular staining was performed using a FOXP3 
staining kit (eBioscience). After staining, cells were washed 2–3 times in PBS 2% FBS, 2 mM 
EDTA and acquired on a MACSQuant Analyzer (Miltenyi Biotec), Cytoflex S (Beckman Coulter) 
or LSRFortessa (BD Biosciences). Data were analyzed using FlowJo software v10 (TreeStar).
Immunoglobulin ELISAs
Intestinal washes were obtained by gently flushing the whole small intestine with 5 ml of wash buffer 
(PBS, 0.05 M EDTA, Complete Mini protease inhibitors, Roche) into a petri dish on ice. Debris 
was removed by centrifuging at 4,000 rpm at 4 °C for 15 minutes, after which the supernatant was 
collected and stored at −80 °C until required. Tissue homogenates were obtained by mechanical 
disruption of tissue (40 mg/ml) in PBS containing protease inhibitors (Complete Mini, Roche). 
Serum and plasma were obtained from tail snip blood sample collections. For normalization, total 
protein concentration of the soluble fraction was measured by BCA assay (Thermo Scientific).
Immunoglobulin levels were measured by standard sandwich ELISA (antibodies listed in Table S2). 
Briefly, ELISA plates (Corning) were coated with capture antibodies and washed extensively 
using an ELISA plate washer (Biotek ELx 405). Plates were then blocked with PBS 1%–2% BSA 
(Fisher) for 1–2 hours at room temperature and washed again. Samples and standards were added to 
wells and incubated for 1–2 hours at room temperature. All samples and serially diluted standards 
were run in duplicate. Plates were then washed and incubated with HRP‑conjugated detection 
antibodies for one hour at room temperature. After washing again, 3,3’,5,5’‑tetramethylbenzidine 
(TMB) substrate (KPL) was added and incubated for 10–15 minutes at room temperature. The 
reaction was stopped by adding 0.18 M H2SO4 and absorbance at 450 nm was read on a microplate 
4reader (VersaMax, Molecular Devices). Analyte concentrations were determined by comparison 
with standards using a four‑parameter logistic regression.
TUDCA treatment of animals
Tauroursodeoxycholic acid (TUDCA, Cayman Chemical) was dissolved in autoclaved tap water at 
a concentration of 2 mg/ml as described previously (32) and provided as drinking water for 14 days. 
The animals were monitored daily, and drinking water was replaced every 48 hours. Water intake 
measurements showed that both TUDCA‑treated and control mice, which received autoclaved 
tap water, consumed an average of 4 ml/d (400 mg/kg body weight assuming an average body 
weight of 20 g). Blood samples were collected by tail snips (baseline) or cardiac puncture (post-
treatment). The post‑treatment sample of one animal could not be obtained for technical reasons.
Intestinal explant culture
For intestinal explant culture, two whole‑layer punches cut by Tru‑Punch™ Sterile Disposable 
Biopsy Punch 6 mm (Sklar) were incubated in 24-well tissue culture plates containing 500 µl of 
RPMI 2% FBS (Atlanta Biologicals), 1% HEPES (Corning), and antibiotic/antimycotic (Gibco) 
at 37 °C and 5% CO2 for 24 hours. The supernatants were analyzed for IL-10 by Cytometric Bead 
Array (CBA, Mouse Th1/Th2/Th17 Cytokine Kit, BD Biosciences) and for TSLP by Mouse TSLP 
Quantikine ELISA Kit (R&D Systems) according to the manufacturer’s instructions.
H&E staining and histology
Small-intestinal tissues from mice were isolated using standard techniques and formalin-fixed, 
paraffin-embedded tissue was stained with hematoxylin and eosin (H&E) as described (5). 
A semi‑quantitative composite scoring system was used for the assessment of spontaneous 
intestinal inflammation, calculated as a sum of four histological subscores: mononuclear cell 
infiltration (0: absent; normal sparse lymphocytic infiltration, 1: mild; diffuse increase in lamina 
propria, 2: moderate; lamina propria increased with basal localization aggregates displacing 
crypts, 3: severe; lamina propria with submucosal infiltration), crypt hyperplasia (0: absent, 
1: mild, 2: moderate, 3: severe), epithelial injury/erosion (0: absent, 1: mild; crypt dropout or 
surface epithelial damage without frank erosion or ulceration, 2: moderate; focal ulceration, 
3: severe; multifocal or extensive ulceration) and polymorphonuclear cell infiltration (0: absent, 
1: mild; lamina propria only, 2: moderate; lamina propria infiltration with cryptitis or crypt 
abscesses, 3: severe; sheet-like or submucosal infiltration). Scores were multiplied by a factor 
based on the extent of the inflammation. Extent factor was derived according to the fraction of 
bowel length involved by inflammation: 1, < 10%; 2, 10%–25%; 3, 25%–50%; and 4, > 50%. 
The score was assessed by an expert gastrointestinal pathologist (J.N.G.) who was blinded to the 
genotype and experimental conditions of the samples.
5Immunohistochemistry and immunofluorescence
Intestinal sections were deparaffinized in xylene and rehydrated in graded ethanol to distilled 
water. For immunohistochemistry, endogenous peroxidase activity was blocked using 3% 
hydrogen peroxide in distilled water for 10 minutes. After heat-mediated antigen retrieval in 
10 mM citrate buffer (pH 6.0), non-specific antibody binding sites were blocked (Animal-Free 
Blocking Solution, Cell Signaling Technologies), and sections were incubated overnight at 4 °C 
with 0.5 µg/ml rabbit anti-mouse IgA antibody (NB7506, Novus Biologicals), 1:125 rabbit anti-
Cre Recombinase (D7L7L, Cell Signaling Technology) or 1:1,600 rabbit anti-human/mouse BiP 
(C50B12, Cell Signaling Technology), respectively. After thorough washing of the sections, an 
HRP-conjugated anti-rabbit polymer (SignalStain Boost IHC Detection Reagent, Cell Signaling 
Technologies) was applied and targets visualized by 3,3′-diaminobenzidine-tetrahydrochloride-
dihydrate (DAB, Cell Signaling Technologies). Sections were counterstained with hematoxylin. 
For immunofluorescence, targets were visualized using 2 µg/ml Alexa Fluor 488–conjugated 
donkey anti-rabbit IgG (A21206, Invitrogen) and nuclei counter-stained with 4′,6-diamidino-2-
phenylindole (DAPI, Invitrogen). No staining was detected in slides incubated without primary 
antibodies or with an isotype control. For IgA quantification, IgA+ cells were counted along ≥ 50 
crypt/villus axes. For epithelial GRP78 (BiP) quantification, the mean staining intensity of epithelial 
layers from three random fields per sample (200-fold magnification) was calculated using ImageJ.
Microbiota flow cytometry
Bacterial flow was performed as described previously (6, 33). Briefly, fresh fecal pellets were 
gently homogenized in 500 µl of staining buffer (PBS, 1% w/v BSA) and centrifuged at 50 × g 
for 15 minutes at 4 °C to remove large non-bacterial particles. The supernatant (100 µl) was 
transferred to a fresh tube, washed with 1 ml staining buffer, centrifuged at 8,000 × g for 5 minutes 
and resuspended again in 1 ml staining buffer. IgA staining was performed by incubating 25 µl of 
the resuspended bacteria with 2.5 µg/ml PE-conjugated anti-IgA antibody (mA-6E1, eBioscience) 
for 30 minutes on ice. Samples were washed two times and resuspended in staining buffer with 
SYBR Green (Thermo Fisher) before flow cytometric analysis (Cytoflex S, Beckman Coulter). 
Bacteria were identified as SYBRhi events as described previously (33).
IgA-seq
Samples were prepared as described above for microbiota flow cytometry. Following staining of 
the bacteria with 16 µg/ml PE-conjugated anti-IgA antibody (mA-6E1, eBioscience) for 30 minutes 
on ice, samples were washed three times. Then, 2 million IgA+ and 2 million IgA− bacteria were 
isolated via FACS (FACSAria; BD Biosciences). Isolated bacteria were pelleted (10,000 × g, 
5 minutes, 4 °C) and frozen along with the pre‑sort samples. 16S rRNA gene sequencing was 
performed as described previously (6).
6Flow cytometric analysis of serum IgA bacterial reactivity
Antibacterial reactivity of serum IgA was assessed as described previously (34). Briefly, sera were 
heat-inactivated at 56 °C for 30 minutes, centrifuged at 16,000 × g for 5 minutes and passed through 
a 0.22-µm spin filter column. Serially diluted sera (in PBS, 1% w/v BSA) were then incubated with 
1.25 × 105 non-IgA-coated bacteria, which were obtained from feces of SPF µMT mice, for 1 hour 
on ice. IgA staining and cytometric acquisition were performed as described above. 
Polyreactivity ELISAs
Polyreactivity of serum IgA was assessed as described previously (25, 35). Briefly, high-binding 
ELISA plates (Corning) were coated overnight with recombinant calf thymus DNA (10 µg/ml, 
Sigma), human insulin (5 µg/ml, Sigma), keyhole limpet hemocyanin (KLH) (10 µg/ml, Sigma), 
LPS from E. coli (10 µg/ml, Sigma) in bicarbonate buffer or cardiolipin (10 µg/ml, Sigma) in 100% 
ethanol. Cardiolipin-coated plates were allowed to dry overnight. Plates were washed five times 
with distilled water using an ELISA plate washer (Biotek ELx 405) and incubated with ELISA 
buffer (PBS, 1 mM EDTA, 0.05% Tween 20) for 1 hour at room temperature. Plates were washed 
five times and serially diluted sera (in PBS) were added for 2 hours at room temperature. Plates 
were washed five times, incubated with HRP-conjugated goat anti-mouse antibody (Bethyl) in 
ELISA buffer for 1 hour and washed again. ELISA buffer was then added, and plates incubated for 
5 minutes at room temperature. Plates were washed again and TMB substrate (KPL) was added. 
Optical densities at 650 nm were monitored using a microplate reader (VersaMax, Molecular 
Devices).
Generation of Peyer’s patch-deficient animals
Peyer’s patch-deficient animals were generated as previously described (21). Briefly, mice were 
mated overnight (day 0). At day 14.5, a single intravenous injection of 3 mg of anti-IL7Rα 
(clone A7R34, BioxCell) was administered to pregnant females under axenic conditions. This 
completely abrogated Peyer’s patch ontogeny in the pups, which was confirmed macroscopically 
and microscopically. 
Parabiosis experiments
Parabiosis was performed as described previously (36). Briefly, co-housed female mice of similar 
weight and size were anesthetized using an isoflurane vaporizer (4%–5% v/v) connected to a Posi-
Seal induction chamber. Anesthesia was maintained throughout the surgical procedure via a nose 
cone connected to isoflurane (1.5%–2% v/v). For analgesia, carprofen and buprenorphine were 
administered i.p. at a dose of 10 mg/kg and 0.1 mg/kg respectively. After aseptically preparing the 
surgical areas (approximately 1 cm above the elbow to 1 cm below the knee), longitudinal skin 
incisions were performed, and the skin was gently detached from the subcutaneous fascia along 
7the incision. Olecranons and knee joints were joint using a non-absorbable 3-0 suture and skin 
connected with a continuous absorbable 5-0 Vicryl suture. Following recovery, analgesics were 
provided at the previously described dosage every 24 hours for 2 days. Furthermore, antibiotic 
prophylaxis with sulfamethoxazole/trimethoprim was administered via drinking water (2 mg/ml 
and 0.4 mg/ml, respectively). Animals were carefully monitored for signs of pain, distress, or 
infection.
RNA isolation and RT-qPCR
RNA from small-intestinal tissue was extracted and purified using RNeasy Mini Kit (Qiagen), 
and complementary DNAs (cDNA) were synthesized using SuperScript III reverse transcriptase 
(Life Technologies). Real‑time RT‑PCR was performed using LightCycler 480 SYBR Green I 
Master (Roche) and a CFX96 Real-Time System (Bio-Rad). Values were normalized to Gapdh 
and relative expression calculated using the 2−ΔΔCT method (37). Primers used for qPCR were as 
follows: 
Gapdh forward: 5′-AGGTCGGTGTGAACGGATTTG-3′,
reverse: 5′-TGTAGACCATGTAGTTGAGGTCA-3′,
Tnfsf13 forward: 5′-GCCAGCCTCATCTCCTTTCTTG-3′, 
reverse: 5′-TGGTTGCCACATCACCTCTGTCAC-3′, 
Tnfsf13b forward: 5′-CTGTGGTCACTTACTCCAAAGG-3′, 
reverse: 5′-GGATCAGATTCAACGGGTCACG-3′,
Ccl25 forward: 5′-TTACCAGCACAGGATCAAATGG-3′,
reverse: 5′-CGGAAGTAGAATCTCACAGCAC-3′,
Ccl28 forward: 5′-AGAGTGAGTTCATGCAGCATC-3′,
reverse: 5′- CTGCTTCAAAGTACGATTGTGC-3′,
Cxcl13 forward: 5′-GGCCACGGTATTCTGGAAGC-3′,
reverse: 5′-GGGCGTAACTTGAATCCGATCTA-3′
Xbp1 splicing assay 
Splicing of Xbp1 was quantified from cDNA of whole-thickness small-intestinal tissue RNA samples 
as described previously (38). Briefly, a region of Xbp1 including the splicing site was amplified by 
PCR using the following primers: Xbp1s forward: 5′ACACGCTTGGGAATGGACAC-3′, reverse: 
5′-CCATGGGAAGATGTTCTGGG-3′. The resulting amplicons of 145 bp (spliced) and 171 bp 
(unspliced) were resolved on a 2% agarose gel with SYBR Safe DNA Gel Stain (Thermo Fisher) 
and visualized using an Odyssey Fc Imaging System (LI-COR Biosciences).
8Immunoblotting
Proteins for immunoblotting were extracted from small‑intestinal tissue by homogenizing 
samples in immunoprecipitation buffer (20 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA and 1% 
Triton-X) with protease inhibitors (Complete Mini, Roche). Thirty micrograms of soluble protein 
(as determined by BCA Protein Assay, Thermo Fisher) was electrophoretically separated on a 
4%–20% gradient tris/glycine gel (Thermo Fisher) and transferred onto nitrocellulose membranes 
(Thomas Scientific). Membranes were blocked with TBS-based Odyssey Blocking buffer 
(LI-COR Biosciences) and incubated at 4 °C overnight in Odyssey Blocking buffer with 0.1% 
Tween and the following primary antibodies: 1:1,000 rabbit anti-IRE1α (14C10, Cell Signaling 
Technology), and 1:1,000 chicken anti-beta actin (ab13822, Abcam). After washing, membranes 
were incubated for 1 hour at room temperature in Odyssey Blocking buffer with 0.1% Tween and 
1:15,000 IRDye 800CW goat anti-rabbit IgG and 1:20,000 IRDye 680LT donkey anti-chicken IgG 
(LI-COR Biosciences). Membranes were visualized using an Odyssey Fc Imaging System (LI-COR 
Biosciences) and band density quantified using Image Studio Software (LI-COR Biosciences).
TUNEL labeling
Apoptotic cell death was assessed on formalin-fixed, paraffin-embedded small-intestinal tissue 
sections by TdT-mediated dUTP nick-end labelling (TUNEL) using a TACS 2 TdT DAB In Situ 
Apoptosis Detection Kit (Trevigen) according to the manufacturer’s protocol. Positive controls 
were obtained by nuclease treatment of sections.
Single-cell RNA-seq
Peritoneal cavity cells of four male, age‑matched GF Xbp1ΔIEC mice and four GF Xbp1fl/fl littermate 
controls were isolated by lavage as described previously and equal cell numbers of each animal 
pooled by genotype. For each pooled sample, 8,700 cells were encapsulated into droplets using 
Chromium Controller (10x Genomics). Libraries were prepared using Chromium Single Cell 
3′ Library Kits v2 (10x Genomics) according to the manufacturer’s protocol. Following quality 
control using a Bioanalyzer 2100 (Agilent), equal quantities of each library were pooled 
and sequenced over two lanes of a HiSeq 2500 Rapid Run Flow Cell (Illumina) using custom 
parameters: Read 1, 26 cycles; i7, 8 cycles; i5, 0 cycles; Read 2, 98 cycles.
Raw scRNA-seq data were processed using the Cell Ranger Pipeline (v2.2.0, 10x Genomics), 
obtaining 6,076 and 6,028 single cells from GF Xbp1ΔIEC and GF Xbp1fl/fl mice, respectively, 
with an average of ~27,000 reads per cell. Both libraries were aggregated using the Cell Ranger 
“aggr” function. Then, DoubletFinder (https://doi.org/10.1101/352484) was used to filter potential 
doublets. Finally, the UMI-collapsed count matrix of the remaining 11,104 single cells was fed to 
Seurat (v2.3.0) to perform clustering analysis and identify potential marker genes (39). Briefly, 
we only included cells with ≥ 200 detected genes and genes detected in ≥ 12 cells, log-normalized 
9the expression data and identified highly variable genes. Finally, shared nearest neighbor (SNN) 
was applied for clustering and t‑distributed stochastic neighbor embedding (t‑SNE) was used to 
visualize the single cell transcriptional profile in 2D space.
RNA-seq
For each sample, 6,000 peritoneal B1b cells (CD19+CD23−CD5−CD3−F4/80−) were isolated by 
FACS with a confirmed post-sort purity of > 90%. RNA was isolated using the RNeasy Plus Micro 
Kit (Qiagen) and concentrations determined using a Bioanalyzer 2100 (Agilent). RIN scores of 
all samples were ≥ 8.9. Library preparation was performed using SMART-Seq v4 Ultra Low Input 
RNA Kit (Takara). Pooled libraries were sequenced by Illumina NextSeq 500 in single-end mode 
using a 75‑cycle high output kit. The number and quality of demultiplexed reads were assayed 
using FastQC v0.11.5 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc). Adaptors 
were trimmed using TrimGalore! v0.4.4 (https://www.bioinformatics.babraham.ac.uk/projects/
trim_galore). Reads were mapped to the NCBI GRCm38.p5 mouse genome using STAR v2.5.2b 
(40) with default settings. Reads per gene were counted using STAR’s “--quantMode GeneCounts” 
function with the Ensembl annotation release 91. Differential expression was assessed using 
DESeq2 v1.18.1 with default parameters (41). Moderated log fold changes, obtained by the 
DEseq2 lfcshrink function, were used for visualization.
For gene set enrichment analysis (GSEA) (42), a pre‑ranked gene list was generated using the 
following formula:
Rank metric = |log2FC|/log2FC × −log10(P‑value)
GSEA was performed using GSEA v3.0 software (Broad Institute) in pre-ranked mode with 1,000 
permutations and classic enrichment score calculation against MSigDB v6.1 collections H and 
C5BP (43, 44).
Human IgA quantification
Previously collected tissue was used for analysis (11). Briefly, after obtaining written informed 
consent, intestinal biopsies from the terminal ileum of 43 healthy controls were collected during 
colonoscopy. Formalin-fixed, paraffin-embedded sections were stained by immunohistochemistry 
as described above, using mouse anti-human IgA antibody (NCL-L-IgA, 1:400, Leica Biosystems) 
and HRP-conjugated horse anti-mouse IgG polymer (Vector Laboratories). Nine samples had low 
tissue quality and were excluded before quantification. IgA+ cells were quantified within three 
randomly selected high-power fields per sample in a blinded fashion.
Genotyping for ATG16L1 (T300A) SNP (rs2241880) was performed as described previously (11). 
Briefly, DNA from EDTA blood samples was extracted (Wizard Genomic DNA purification kit; 
Promega) and a 330-bp fragment containing the ATG16L1 (T300A) SNP amplified by High-Fidelity 
PCR (Phusion; Thermo Fisher Scientific) using forward primer 5′-TTGGAGTCCACAGGTTAG-3′ 
10
and reverse primer 5′-CAGTAGCTGGTACCCTCACTTC-3′ (11). PCR products were run on a 1% 
agarose gel and the appropriate fragment cut and purified (QIAQuick gel extraction kit, Qiagen). 
Sanger sequencing of the amplicons was then performed using the forward primer. All protocols 
were approved by Cambridgeshire 4 Research Ethics Committee (reference 03/5/012). Patient 
characteristics were reported previously (11).
IgA repertoire sequencing
Illumina-based antibody repertoire sequencing library pools were sequenced on the Illumina MiSeq 
platform (2 × 250 cycles, paired-end) with 10% PhiX control library. Mean base-call quality of 
all samples was in the range of Phred score 30. The resulting FASTQ files were preprocessed 
(VDJ alignment, clonotyping) using the MiXCR software package (clonotype formation by CDR3 
amino acid region, annotated using C57BL/6J germline gene data, https://github.com/milaboratory/
mixcr) (45). Error correction was performed by combining previously published bioinformatics 
workflows (reduction of artificial diversity by singleton exclusion and CDR3 length restriction) with 
the MiXCR platform (46). PCR and sequencing errors were corrected using the built‑in function of 
MiXCR for clonotyping by multilayer clustering (assembly of consensus CDR3 sequences having 
homologous and identical CDR3s). 
For all analyses, clones were defined by 100% amino acid sequence identity of CDR3 regions. 
CDR3 regions were defined by MiXCR according to the nomenclature of the Immunogenetics 
database (IMGT) (47). MIXCR output files were further processed in VDJtools post-analysis 
framework (https://github.com/mikessh/vdjtools) (48). Further filtering was applied in order to keep 
only in‑frame, productive sequences. Basic statistic segment usage was calculated, and weighted 
variable usage profiles were hierarchically clustered and visualized as a heatmap. Repertoire 
overlap was measured by calculating the geometric mean of relative overlap frequencies between 
variable segment usage profiles or CDR3 usage. The relative overlap similarity was represented as 
hierarchical clustering or multi‑dimensional scaling (MDS) plot.
Statistical analysis
Statistical significance was determined as indicated in the figure legends. Differences were 
considered significant at P < 0.05. Data were analyzed using GraphPad Prism v7 (GraphPad 
Software).
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Fig. S1. IEC-restricted expression of Cre recombinase in Xbp1ΔIEC mice and gating strategy 
for small-intestinal LP IgA+ plasma cells. (A) IHC for Cre recombinase (brown) in ileal tissue 
of wild‑type C57BL/6J (WT) and Xbp1ΔIEC mice (n = 2, one experiment). (B) Gating strategy. Plots 
are representative of multiple independent experiments. Scale bars, 100 μm.
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Fig. S2. The IEC ER stress induced immunoglobulin response is specific for IgA. (A) Ileal 
intra-tissue IgG and IgM concentrations (c, normalized by total soluble tissue protein) in Xbp1ΔIEC 
mice Xbp1fl/fl controls (n = 7–10). (B) Serum immunoglobulin concentrations (n = 10–12). Symbols 
represent individual animals. Bars represent geometric means. P‑values were calculated by 
unpaired Student’s t‑test. All data are representative of two independent experiments.
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Fig. S3. IRE1α is critical for the IEC ER stress induced IgA response. Quantification of small-
intestinal IgA+ cells along ≥ 50 ileal crypt-villus axes (n = 5–9). Data represent two independent 
cohorts that were housed in the indicated facilities. Symbols represent individual animals. Bars 
represent arithmetic means. P‑values were calculated by unpaired Student’s t‑test.
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Fig. S4. Treatment of Xbp1ΔIEC mice with TUDCA reduces epithelial ER stress. 
(A) Representative IHC images for GRP78 (brown) in ileal tissue of Xbp1ΔIEC mice and Xbp1fl/fl 
controls after treatment with either TUDCA (2 mg/ml) in the drinking water or plain water (control) 
for two weeks. (B) Quantification of epithelial GRP78 staining intensity (n = 6, data from one 
experiment). Scale bars, 20 μm. Symbols represent individual animals. Bars represent arithmetic 
means. P-values were calculated by two-way ANOVA with Fishers LSD method and two-stage 
step‑up method of Benjamini, Krieger and Yekutieli to control the false discovery rate. *P < 0.05, 
**P < 0.01, ***P < 0.001.
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Fig. S5. Jejunal enteritis in Xbp1ΔIEC mice that lack IgA, B cells or the pIgR. H&E staining of 
the proximal jejunum of the indicated genotypes. Images are representative of the corresponding 
groups depicted in Fig. 1J, K and O (n = 4–26, data pooled from 4 independent cohorts). Scale bars, 
100 μm.
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Fig. S6. No small-intestinal LP IgA+ cells in µMT Xbp1ΔIEC mice. Representative IHC images 
for IgA (brown) in ileal sections of C57BL/6J, µMT Xbp1fl/fl and µMT Xbp1ΔIEC mice (n = 2). 
Data are representative of two independent experiments. Scale bars, 100 μm.
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Fig. S7. Igha−/−Xbp1ΔIEC mice exhibit low levels of compensatory tissue IgM. Symbols represent 
individual animals (n = 7–11). Data are representative of two independent experiments. IgA 
concentrations (per mg of SI tissue) from C57BL/6J Xbp1ΔIEC mice as presented in Fig. 1B are 
shown for comparison. Bars represent arithmetic means. P-values were calculated by unpaired 
Student’s t‑test. *P < 0.05, **P < 0.01, ***P < 0.001.
18
IL
10
-G
FP
FSC-A
Vert-X Xbp1fl/fl Vert-X Xbp1∆IEC 
B
0 23 18
0
10
20
30
40
50
IL
10
-G
FP
 (%
) ns
C57BL/6J
Ve
rt-
X
Xb
p1
∆IE
C
Ve
rt-
X
Xb
p1
fl/f
l
0
20
40
60
80
100
IL
-1
0 
(p
g/
m
g 
tis
su
e 
pr
ot
ei
n) ns
A
C57BL/6J µMT
Xbp1fl/fl
Xbp1∆IEC
Fig. S8. The IEC ER stress induced IgA response is not associated with increased IL-10. 
(A) Ileal tissue IL-10 normalized by total soluble tissue protein (n = 5, one experiment). 
(B) Representative plots and frequencies of IL-10 reporter+ B cells (gated on CD45+CD19+ LP 
lymphocytes) in the indicated genotypes (n = 4, one experiment). Symbols represent individual 
animals. Bars represent arithmetic means. P-values were calculated by one-way ANOVA (A) or 
unpaired Student’s t‑test (B).
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Fig. S9. No differences in IgA coating of fecal bacteria between Xbp1ΔIEC mice and Xbp1fl/fl 
controls. Heatmaps of IgA-SEQ results depict relative abundance of genera in the fecal samples 
(pre-sort) and their IgA coating index (ICI). Each column represents an individual animal of the 
indicated genotype (n = 3–5, one experiment).
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Fig. S10. No increase of compensatory γδ T cells in TCRβ−/−Xbp1ΔIEC mice. Absolute counts of 
small‑intestinal lamina propria γδ T cells (CD45+TCRγδ+) in TCRβ−/−Xbp1fl/fl and TCRβ−/−Xbp1ΔIEC 
mice (n = 5, one experiment). Symbols represent individual animals. Bars represent geometric 
means. P‑values were calculated by unpaired Student’s t‑test.
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Fig. S11. PP-deficient Xbp1ΔIEC mice do not develop spontaneous jejunal inflammation. 
Small‑intestinal inflammation scores of Peyer’s patch–deficient (PPdef) Xbp1ΔIEC mice and Xbp1fl/fl  
controls (n = 7–13). Symbols represent individual animals. Bars represent medians. Data are 
compiled from two independent experiments. P-values were calculated by Mann–Whitney U test. 
*P < 0.05, **P < 0.01, ***P < 0.001.
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Fig. S12. Gating strategy for parabiosis experiment. (A) Gating of blood B and T cells. 
(B) Gating of peritoneal B1a and B1b cells. Plots are representative of all animals from the 
parabiotic experiment (n = 7–8 pairs per genotype).
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Fig. S13. Similar expression of cytokines associated with IgA class switching and plasma 
cell recruitment in in Xbp1ΔIEC mice and Xbp1fl/fl controls. (A) Quantitative RT‑PCR expression 
analysis of the noted cytokines (normalized to Gapdh) in SI tissue of Xbp1ΔIEC mice and Xbp1fl/fl  
controls (n = 5–7, one experiment). (B) Concentration of TSLP in SI tissue lysates (n = 4, one 
experiment) or supernatant of SI explant cultures (n = 8, one experiment) of Xbp1ΔIEC mice and 
Xbp1fl/fl controls. Symbols represent individual animals. Bars represent arithmetic means. P‑values 
were calculated by unpaired Student’s t‑test.
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Fig. S14. Germ-free Xbp1ΔIEC mice exhibit small-intestinal ER stress but low rates of 
apoptotic events. (A) Immunoblot of whole-thickness SI tissue lysates from GF Xbp1ΔIEC mice and 
GF Xbp1fl/fl controls for IRE1α (n = 4–5, data from one experiment). (B) Densitometry of (A), 
normalized to β-Actin. (C) Xbp1 splicing in whole-thickness SI tissue samples from GF 
Xbp1ΔIEC mice and GF Xbp1fl/fl controls (n = 4–5, data from one experiment). Xbp1u, unspliced form 
(171 bp). Xbp1s, spliced form (145 bp). (D) Representative images of TUNEL-labeled SI sections 
of the indicated genotypes and housing conditions. Positive control was obtained by nuclease 
treatment of sections. The experiment was performed once. Symbols represent individual animals. 
Bars represent arithmetic means. P‑values were calculated by unpaired Student’s t‑test. Scale bars, 
100 μm.
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Fig. S15. Germ-free but not SPF Xbp1ΔIEC mice show increased numbers of colonic IgA 
plasma cells and levels of tissue IgA. (A) Representative IHC images and quantification of 
colonic LP IgA+ cells (brown) along ≥ 50 crypts (n = 4–10, one experiment). (B) Colonic intra‑
tissue IgA normalized by total soluble tissue protein (n = 4–8, one experiment). Scale bars, 100 μm. 
Symbols represent individual animals. Bars represent arithmetic means. P‑values were calculated 
by unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.
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Fig. S16. Single-cell RNA sequencing reveals transcriptional identities of peritoneal cavity 
cells in germ-free mice. (A) Heatmap showing expression of top 10 marker genes (z-score −2.5 to 
+2.5; blue to red) by cluster as defined in Fig. 3F. (B) Violin plots showing expression probability 
distributions of selected genes across clusters as defined in Fig. 3F. Note the high expression of 
Lifr and low expression of Fcmr in cluster 2, consistent with a B1b transcriptional phenotype as 
previously described (immgen.org). Both panels depict the aggregated data obtained from germ‑
free Xbp1ΔIEC and Xbp1fl/fl mice (n = 11,104 cells). The experiment was performed once.
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Fig. S17. No differences in peritoneal myeloid and T cells between GF Xbp1ΔIEC mice and 
GF Xbp1fl/fl controls. (A) Gating strategy. (B) Frequencies of myeloid and T cells among peritoneal 
cavity cells of GF Xbp1ΔIEC mice and GF Xbp1fl/fl controls (n = 4–7). Data are representative of 
two independent experiments. MΦ, macrophages. PMN, polymorphonuclear leukocytes. Symbols 
represent individual animals. Bars represent arithmetic means. P‑values were calculated by 
unpaired Student’s t‑test.
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Fig. S18. No differences in small-intestinal LP myeloid cell populations between GF Xbp1ΔIEC 
mice and GF Xbp1fl/fl controls. (A) Absolute counts of small‑intestinal LP dendritic cells (DC, 
CD45+CD3−CD19−NK1.1−Ly6G−CD64−MHCII+CD11chi) and macrophages (MΦ, CD45+CD3−
CD19−NK1.1−Ly6G−CD64+) in GF Xbp1ΔIEC mice and GF Xbp1fl/fl controls (n = 4, one experiment). 
(B) Frequencies of CD11b+, CD103+ and CD11b+CD103+ subsets of small‑intestinal LP DCs. 
Gating strategy as described previously (49). Symbols represent individual animals. Bars represent 
geometric means (A) or arithmetic means (B). P‑values were calculated by unpaired Student’s 
t‑test.
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Fig. S19. IgA repertoire analysis of small-intestinal LP cells from germ-free Xbp1ΔIEC mice 
confirms a polyclonal IgA response. (A) Heatmap depicting variable segment usage in IgA 
from jejunal (left) and ileal (right) samples of germ‑free (GF) Xbp1ΔIEC and Xbp1fl/fl mice (n = 5–8, 
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experiment performed once). Each column represents an individual animal of the indicated 
genotype. Color indicates column z‑score. (B) Repertoire overlap as assessed by cluster analysis 
using multi‑dimensional scaling (MDS) and hierarchical clustering. The geometric mean of relative 
overlap frequencies of clonotypes (defined by exact match of CDR3 amino acid sequences) was 
used as an overlap metric. (C) Heatmap depicting the abundance of the Top100 shared clonotypes 
between the different mice. Each column represents an individual animal of the indicated genotype. 
(D) Mutation load expressed as the median number of mutations per clonotype.
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Supplementary Tables
Table S1: Antibodies used for flow cytometry.
Target Clone Fluorochromes Vendor Dilution
CD3 17A2 APC/Cy7, FITC, PerCP/
Cy5.5
Biolegend 1:100
CD5 53‑7.3 APC BD 1:200
CD11b M1/70 eFluor 450 eBioscience 1:400
CD11c N418 PE/Cy7 Biolegend 1:400
CD19 6D5 APC/Cy7, PE Biolegend 1:200
CD23 B3B4 PE/Cy7 Biolegend 1:200
CD43 eBioR2/60 PE eBioscience 1:200
CD45 30-F11 Alexa Fluor 700 Biolegend 1:800
CD45.1 A20 BV605 Biolegend 1:800
CD45.2 104 BV786 BD 1:400
CD45R/B220 RA3‑6B2 PE/Cy7 Biolegend 1:400
CD64 X54-5/7.1 APC Biolegend 1:200
CD95 Jo2 PE Biolegend 1:100
CD103 M290 PE BD 1:200
CD115 (CSF1R) AFS98 FITC Thermo Fisher 1:100
CXCR5 2G8 Biotin eBioscience 1:50
F4/80 BM8 APC/Cy7, FITC Biolegend 1:200
GL7 GL7 FITC Biolegend 1:100
I-A/I-E M5/114.15.2 Alexa Fluor 700 eBioscience 1:200
IgA C10-3 Alexa Fluor 647†, FITC BD 1:800–1:1,200*
IgM R6-60.2 FITC BD 1:800
Ly6G 1A8 APC/Cy7 Biolegend 1:400
NK‑1.1 PK136 APC/Cy7 Biolegend 1:100
PD‑1 29F.1A12 FITC Biolegend 1:100
TCRβ H57‑597 eFluor 450, FITC eBioscience 1:100
TCRγ/δ GL3 APC Biolegend 1:100
*intracellular staining, †custom conjugation (Alexa Fluor 647 Labeling Kit, Molecular probes).
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Table S2: Antibodies used for immunoglobulin ELISA.
Target Capture antibody Detection antibody (HRP)
IgM 1020-01, SouthernBiotech, 1 µg/µl
or A90-101A, Bethyl, 10 µg/µl
A8786, Sigma-Aldrich, 1:1,000
A90-101P, Bethyl, 1:50,000
IgG1 1070-01, SouthernBiotech, 1 µg/µl A3673, Sigma-Aldrich, 1:1,000
IgG2a 1080-01, SouthernBiotech, 1 µg/µl A3673, Sigma-Aldrich, 1:1,000
IgG2b 1090-01, SouthernBiotech, 1 µg/µl A3673, Sigma-Aldrich, 1:1,000
IgG3 1100-01, SouthernBiotech, 1 µg/µl A3673, Sigma-Aldrich, 1:1,000
IgG-Fc A90-131A, Bethyl, 10 µg/µl A90-131P, Bethyl, 1:50,000
IgA 1040-01, SouthernBiotech, 1 µg/µl
or A90-103A, Bethyl, 10 µg/µl
A4789, Sigma-Aldrich, 1:1,000
A90-103P, Bethyl, 1:20,000
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